For most people weighing CBT vs medication for anxiety, the short-term results are close to even. The real differences are speed and staying power: medication helps faster, while CBT’s gains tend to last after treatment ends. NICE guidance leans the same way, putting CBT-shaped support first for most anxiety and holding medication as an equal choice when things are more severe.
I have this conversation most weeks, and almost everyone arrives having already read themselves into a stalemate. Both routes work. Both ask something of you. What follows is how I’d walk you through the choice in a first session, including the UK-specific parts most summaries skip. I’ve written separately about CBT vs medication for depression; this guide is about anxiety, because the calculation isn’t identical.
What does NICE recommend first for anxiety?
The UK guideline for generalised anxiety disorder and panic disorder, NICE CG113, is built as a stepped-care model. It tells clinicians to offer “the least intrusive, most effective intervention first” (rec 1.2.1). Treatment starts with education and low-intensity, CBT-based support. Medication doesn’t enter the pathway until step 3, for anxiety that’s more severe or hasn’t shifted. At that stage the guideline offers a straight choice between a high-intensity psychological intervention, usually CBT, and drug treatment (rec 1.2.17).
The next line of that recommendation deserves quoting in full, because none of the comparison articles carry it. “Base the choice of treatment on the person’s preference as there is no evidence that either mode of treatment (individual high-intensity psychological intervention or drug treatment) is better.” At that fork, your preference isn’t a tiebreaker your doctor tolerates; it’s the deciding criterion the guideline instructs them to use. Note the order, too. The NHS’s own patient page says a GP “will usually advise you to try talking therapies before they prescribe medicine”.
Generalised anxiety disorder, the GAD in the guideline’s title, means persistent, hard-to-control worry that spreads across most areas of life. Panic disorder has its own recommendations in the same guideline, and social anxiety a separate one. Each puts a condition-specific form of CBT at the front of the queue. For panic disorder, the psychological recommendation runs to four words: “CBT should be used” (rec 1.3.13).
What each treatment does, and how fast it works
CBT for anxiety trains a concrete skill. You learn to catch the thought, or the avoidance, that keeps the threat response switched on, and test it against evidence. Then you retrain the response itself through deliberate, graded practice with the situations you’ve been dodging. An SSRI such as sertraline works on the physiology instead, gradually turning down the background volume across several weeks.
I’ve broken the skill side down elsewhere, in my step-by-step guide to cognitive reframing for anxiety and my longer guide to how CBT works. The medication side is slower than most people expect. The first few weeks often serve up the side effects before any of the benefit. That’s when people give up on a tablet that might have worked.
CBT is not “side-effect free”, whatever the comparison tables say. Facing what you’ve avoided raises anxiety before it lowers it. The homework arrives in precisely the weeks you have the least to give, and some people stop early because of that. The costs are real, just a different sort from the medication kind. Pretending there are none sets you up to feel you’re flunking the supposedly easy option.
CBT vs medication for anxiety: which works better in the long run?
The gap opens after treatment ends. The strongest durability data comes from van Dis and colleagues, who in 2020 pooled 69 trials of CBT for anxiety-related disorders in JAMA Psychiatry. Benefits were still measurable a full 12 months after treatment finished. For generalised anxiety, social anxiety and PTSD, they lasted beyond the year.
Medication plays by different rules. It holds the line only while the prescription runs. CG113 itself lists the drug route’s “withdrawal syndromes” among the disadvantages clinicians must explain before you choose (rec 1.2.17).
That durability is the strongest argument for the therapy route when you can afford the slower start: you keep the tool. Three caveats keep the claim honest. The trials behind it were mostly small and imperfect. The gains hold best when you keep using what you learned. Some anxiety returns anyway, in which case a short top-up course is normal rather than a failure. And against placebo, CBT’s average effect in adult anxiety trials is moderate, at its strongest in generalised anxiety (Carpenter and colleagues, 2018). Anyone selling you certainty, in either direction, is reading different evidence.
What if sertraline isn’t working for your anxiety?
In the UK, sertraline is usually the first tablet offered for anxiety. NICE suggests trying it first for GAD because it’s “the most cost-effective drug” (rec 1.2.23). In the same breath, the guideline notes sertraline didn’t hold UK marketing authorisation for this use when it was published. Prescribing off-label here is routine and perfectly legal. It rarely comes up when the prescription is handed over, though, and finding out later can rattle trust the evidence doesn’t warrant.
Prescribers usually judge an SSRI only after several weeks at the dose they’ve set. Agree with your GP at the outset how long you’ll give it, and what change you’d both expect to see. Something more concrete than “do I feel better”. If sertraline genuinely hasn’t helped, the guideline’s next step is an alternative SSRI or an SNRI (rec 1.2.24). That choice weighs withdrawal risk, side effects and safety. If you can’t tolerate either class, NICE’s next option is pregabalin (rec 1.2.25). A failed first tablet is information about that drug, and the guideline treats switching as routine.
If you started with medication alone, a non-response is also the moment to bring the therapy leg in, instead of cycling through prescriptions indefinitely. One route NICE closes off: benzodiazepines are for short-term crisis use only in GAD (rec 1.2.26). For panic disorder, the guideline says they shouldn’t be prescribed at all.
Using CBT and medication together for anxiety
Plenty of people use CBT and medication at the same time. CG113 presents step 3 as a choice between them, but nothing stops you running both. In practice, that’s often the sensible call for more severe anxiety. Each covers the other’s blind spot. The SSRI turns the physiological volume down far enough for you to think. CBT spends that headroom on skills that outlast the prescription.
The practical route splits in two, and you can run both at once. Your GP handles prescribing. NHS Talking Therapies takes self-referrals in England, no GP appointment needed, and anxiety-focused CBT is its core business. Waits vary by area, which is the candid reason some people start medication first. They use the waiting months to steady themselves, then begin CBT when the slot arrives.
Private CBT sidesteps the queue, with a first session usually available within days. Any private therapist should hold UKCP, BACP or HCPC registration, and that’s the floor. The real differentiator is anxiety-specific training, so ask how much of their caseload is anxiety work and which approach they use for it.
Which should you try first?
If your anxiety is mild enough that you can still work with it, the UK pathway and the durability evidence point the same way. Start with CBT, privately or through NHS Talking Therapies. If it’s too severe to take in a single page, medication first is a respectable, guideline-backed way of getting to where therapy is workable.
Still torn after all of that? Then the CBT vs medication for anxiety question probably has no wrong answer for you. Both routes are genuinely open, and that’s where NICE says your preference gets to decide. If you’d like to think it through with a clinician rather than a search box, that’s a conversation I offer. You can read about anxiety therapy at Kind Soul Psych or enquire about an initial consultation. We’ll weigh the choice against your actual week.
If you’re in crisis now, or having thoughts of ending your life, call 999 or go to A&E. You can also call NHS 111 and select the mental health option. Samaritans answer 116 123 at any hour.
Ready to talk it through?
If anything here resonated, you don’t have to work through it alone. Book a free, no-obligation 20-minute discovery call with Sabbir Ahmed, UKCP-registered psychotherapist and EMCC-accredited coach, to talk through where you are and find the right way forward.
Frequently asked questions
Is CBT better than medication for anxiety?
For most anxiety disorders the two perform similarly while treatment lasts. CBT tends to keep its gains after it ends, which is why UK guidance leans towards talking therapy first for milder anxiety. Medication acts faster and asks less of you week to week. Severity, speed and your own preference should make the decision, and changing course later is allowed.
What is the first medication a GP usually prescribes for anxiety in the UK?
Usually sertraline, an SSRI. NICE suggests it first for generalised anxiety disorder on cost-effectiveness grounds. It noted sertraline wasn’t licensed for GAD when the guideline was written; off-label, but routine and evidence-based. If sertraline doesn’t suit you or doesn’t help, an alternative SSRI or an SNRI is the standard next step.
How long does CBT for anxiety take to work?
Many people feel movement within the first few sessions. Exposure-based work puts the hardest sessions near the start, so expect the early weeks to ask the most of you. A full NICE-recommended course for generalised anxiety runs 12 to 15 weekly sessions, fewer if you recover sooner (rec 1.2.19).
Can I stop my medication once CBT starts working?
Don’t stop abruptly, and don’t decide alone. SSRIs should be tapered gradually with the prescriber once things have been stable for a sensible stretch. Some people plan the taper for the tail end of CBT, so the skills are fully in place as the medication goes. That’s a decision to make with your GP and therapist together.
References
- NICE, Generalised anxiety disorder and panic disorder in adults: management (CG113), Recommendations
- van Dis EAM et al., Long-term outcomes of cognitive behavioral therapy for anxiety-related disorders: a systematic review and meta-analysis, JAMA Psychiatry, 2020
- Carpenter JK et al., Cognitive behavioral therapy for anxiety and related disorders: a meta-analysis of randomized placebo-controlled trials, Depression and Anxiety, 2018
- NHS, Generalised anxiety disorder (GAD), Treatment
- NHS England, NHS Talking Therapies for anxiety and depression